Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

Affiliations

• ¹ Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
• ² Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
• ³ Molecular and Cellular Pathology Program, University of Michigan, Ann Arbor, MI, USA.
• ⁴ Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
• ⁵ Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
• ⁶ Aurigene Discovery Technologies, Electronic City Phase II, Bangalore, India.
• ⁷ Dovetail Genomics, Scotts Valley, CA, USA.
• ⁸ Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA.
• ⁹ Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ¹⁰ Department of Internal Medicine/Oncology, University of Michigan, Ann Arbor, MI, USA.
• ¹¹ Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
• ¹² Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.
• ¹³ Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA. arul@umich.edu.
• ¹⁴ Department of Pathology, University of Michigan, Ann Arbor, MI, USA. arul@umich.edu.
• ¹⁵ Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. arul@umich.edu.
• ¹⁶ Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA. arul@umich.edu.
• ¹⁷ Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA. arul@umich.edu.
• ¹⁸ Department of Urology, University of Michigan, Ann Arbor, MI, USA. arul@umich.edu.